MedKoo Cat#: 146371 | Name: Pentigetide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pentigetide is a synthetic peptide with immunomodulatory properties, primarily investigated for its potential in treating autoimmune diseases and inflammatory conditions. It functions by modulating cytokine production, particularly inhibiting pro-inflammatory cytokines such as TNF-α and IL-1β. This mechanism helps reduce inflammation and immune system overactivity.

Chemical Structure

Pentigetide
Pentigetide
CAS#62087-72-3

Theoretical Analysis

MedKoo Cat#: 146371

Name: Pentigetide

CAS#: 62087-72-3

Chemical Formula: C22H36N8O11

Exact Mass: 588.2504

Molecular Weight: 588.58

Elemental Analysis: C, 44.90; H, 6.17; N, 19.04; O, 29.90

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Pentigetide; Pentyde;
IUPAC/Chemical Name
L-aspartyl-L-seryl-L-aspartyl-L-prolyl-L-arginine
InChi Key
KQDIGHIVUUADBZ-PEDHHIEDSA-N
InChi Code
1S/C22H36N8O11/c23-10(7-15(32)33)17(36)29-13(9-31)18(37)28-12(8-16(34)35)20(39)30-6-2-4-14(30)19(38)27-11(21(40)41)3-1-5-26-22(24)25/h10-14,31H,1-9,23H2,(H,27,38)(H,28,37)(H,29,36)(H,32,33)(H,34,35)(H,40,41)(H4,24,25,26)/t10-,11-,12-,13-,14-/m0/s1
SMILES Code
N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 588.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Mansmann HC Jr, Rosen J, Ziering R, Hampel F, Ratner P, Findlay S, Kniker W, Haddad Z, Daigle A. Pentigetide nasal solution: a multicenter study evaluating efficacy and safety in patients with seasonal allergic rhinitis. Ann Allergy. 1991 Oct;67(4):409-15. PMID: 1952297. 2: Kalpaxis JG, Thayer TO. Double-blind trial of pentigetide ophthalmic solution, 0.5%, compared with cromolyn sodium, 4%, ophthalmic solution for allergic conjunctivitis. Ann Allergy. 1991 May;66(5):393-8. PMID: 1903616. 3: Hamburger RN. Pentapeptide activity. Ann Allergy. 1992 Jan;68(1):68. PMID: 1736721. 4: Casillas Miranda R, Boudet RV, Vanella LM. Alternativas de la inmunoterapia clásica y posibilidades futuras [Alternatives to classical immunotherapy and future possibilities]. Rev Alerg Mex (1987). 1990 Jul-Aug;37(4):133-5. Spanish. PMID: 2089604. 5: Coutts SM, Reid DM. Purification of small peptides labeled with Bolton-Hunter reagent. Anal Biochem. 1978 Dec;91(2):446-50. doi: 10.1016/0003-2697(78)90530-4. PMID: 9762130. 6: Bennetts JS, Fowles LF, Berkman JL, van Bueren KL, Richman JM, Simpson F, Wicking C. Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP). Gene. 2006 Jun 7;374:153-65. doi: 10.1016/j.gene.2006.01.027. Epub 2006 Mar 20. PMID: 16546331. 7: MURAKAMI T. The coloring matters of Xanthoria fallax (Hepp.) Arn. fallacinal and fallacinol. Pharm Bull. 1956 Aug;4(4):298-302. doi: 10.1248/cpb1953.4.298. PMID: 13378955. 8: MESCHIA G. A rigid membrane for measurement of colloidal osmotic pressure with the Hepp osmometer. Yale J Biol Med. 1954 Dec;27(3):206-12. PMID: 13226958; PMCID: PMC2599420. 9: Cohen GA, O'Connor RD, Hamburger RN. Safety and efficacy of human IgE pentapeptide. Ann Allergy. 1984 Feb;52(2):83-6. PMID: 6364896. 10: Prenner BM. Double-blind placebo-controlled trial of intranasal IgE pentapeptide. Ann Allergy. 1987 May;58(5):332-5. PMID: 3578925. 11: DESPLAS B. A propos de la communication de M.J. Hepp sur les anastomoses bilio-digestives [On J. Hepp's article on bilio-digestive anastomoses]. Mem Acad Chir (Paris). 1951 May 23-30;77(18-19):587-8. Undetermined Language. PMID: 14863046. 12: Casillas Miranda R, Boudet RV, Vanella LM. Alternativas de la inmunoterapia clásica y posibilidades futuras [Alternatives to classic immunotherapy and future possibilities]. Rev Alerg Mex (1987). 1990 May-Jun;37(3):101-4. Spanish. PMID: 2087619. 13: RADERMECKER MA, VAN BOGAERT L. Deux observations de polymyosite aiguë généralisée (Wagner-Hepp) [Two case reports on acute disseminated Wagner-Hepp polymyositis]. Rev Neurol (Paris). 1955;92(3):182-94. French. PMID: 13255494.